Identification of VIM-2-Producing Pseudomonas aeruginosa from Tanzania Is Associated with Sequence Types 244 and 640 and the Location ofblaVIM-2in a TniC Integron

Comparison of Local Features from Two Spanish Hospitals Reveals Common and Specific Traits at Multiple Levels of the Molecular Epidemiology of Metallo-β-Lactamase-Producing Pseudomonas spp.

(2014) Esther Viedma et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extensively Drug-Resistant Pseudomonas aeruginosa Isolates ContainingblaVIM-2and Elements of Salmonella Genomic Island 2: a New Genetic Resistance Determinant in Northeast Ohio

(2014) Federico Perez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries

(2014) M. Castanheira et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dissemination of a Class I Integron Carrying VIM-2 Carbapenemase in Pseudomonas aeruginosa Clinical Isolates from a Hospital Intensive Care Unit in Annaba, Algeria

(2013) Meriem Touati et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenemase-producing Pseudomonas aeruginosafrom central Greece: molecular epidemiology and genetic analysis of class I integrons

(2013) Apostolos Liakopoulos et al.   BMC INFECTIOUS DISEASES

Outbreak of metallo- -lactamase VIM-2-positive strains of Pseudomonas aeruginosa in the Ivory Coast

(2013) K. Jeannot et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dissemination of metallo- -lactamase-producing Pseudomonas aeruginosa of sequence type 235 in Asian countries

(2013) M. J. Kim et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study

(2013) Mikhail V Edelstein et al.   LANCET INFECTIOUS DISEASES

Molecular Epidemiology and Multidrug Resistance Mechanisms of Pseudomonas aeruginosa Isolates from Bulgarian Hospitals

(2013) Rossitza Vatcheva-Dobrevska et al.   Microbial Drug Resistance

“Stormy waters ahead”: global emergence of carbapenemases

(2013) Gopi Patel et al.   Frontiers in Microbiology

Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones

(2012) Gabriel Cabot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

VIM-2 metallo- -lactamase-producing Pseudomonas aeruginosa causing an outbreak in South Africa

(2012) R. K. Jacobson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence of NDM-1 Metallo-β-Lactamase inPseudomonas aeruginosaClinical Isolates from Serbia

(2011) Branko Jovcic et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Wide Dispersion of ST175 Clone despite High Genetic Diversity of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Clinical Strains in 16 Spanish Hospitals

(2011) M. Garcia-Castillo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa

(2011) Souha S. Kanj et al.   MAYO CLINIC PROCEEDINGS

Identification of Nonclonal Pseudomonas aeruginosa Isolates with Reduced Colistin Susceptibility in Korea

(2011) Ji-Young Lee et al.   Microbial Drug Resistance

Population Structure of Pseudomonas aeruginosa from Five Mediterranean Countries: Evidence for Frequent Recombination and Epidemic Occurrence of CC235

(2011) Makaoui Maatallah et al.   PLoS One

The Colistin-Only-Sensitive Brazilian Pseudomonas aeruginosa Clone SP (Sequence Type 277) Is Spread Worldwide

(2010) E. L. d. Fonseca et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diversity of β-Lactamases in Pseudomonas aeruginosa Isolates Producing Metallo-β-Lactamase in Two Tunisian Hospitals

(2010) Sonia Ktari et al.   Microbial Drug Resistance

Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic

(2010) Alexandr Nemec et al.   RESEARCH IN MICROBIOLOGY

Molecular Epidemiology of Metallo- -Lactamase-Producing Pseudomonas aeruginosa Isolates from Norway and Sweden Shows Import of International Clones and Local Clonal Expansion

(2009) O. Samuelsen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis

(2009) S. Hammami et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms

(2009) P. D. Lister et al.   CLINICAL MICROBIOLOGY REVIEWS

Metallo-β-lactamase–producing Pseudomonas aeruginosa isolates in Tunisia

(2009) Wejdene Mansour et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

The First Metallo- -Lactamase Identified in Norway Is Associated with a TniC-Like Transposon in a Pseudomonas aeruginosa Isolate of Sequence Type 233 Imported from Ghana

(2008) O. Samuelsen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya

(2008) J.D.D. Pitout et al.   CLINICAL MICROBIOLOGY AND INFECTION

Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary

(2008) Dora Szabo et al.   Annals of Clinical Microbiology and Antimicrobials